142 related articles for article (PubMed ID: 35233214)
1. Late primary angioplasty (beyond 12 h): are we sure it should be avoided?
Bolognese L
Eur Heart J Suppl; 2021 Oct; 23(Suppl E):E36-E39. PubMed ID: 35233214
[TBL] [Abstract][Full Text] [Related]
2. Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.
Nepper-Christensen L; Lønborg J; Høfsten DE; Ahtarovski KA; Bang LE; Helqvist S; Kyhl K; Køber L; Kelbæk H; Vejlstrup N; Holmvang L; Engstrøm T
Circ Cardiovasc Interv; 2018 Sep; 11(9):e006842. PubMed ID: 30354595
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
[TBL] [Abstract][Full Text] [Related]
4. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
Morrison DA; Berman M; El-Amin O; McLaughlin RT; Bates ER
Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
[TBL] [Abstract][Full Text] [Related]
5. [Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010].
Silber S
Herz; 2010 Dec; 35(8):558-64. PubMed ID: 21107514
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcomes of Patients With Late Presentation of ST-Segment Elevation Myocardial Infarction.
Cho KH; Han X; Ahn JH; Hyun DY; Kim MC; Sim DS; Hong YJ; Kim JH; Ahn Y; Hwang JY; Oh SK; Cha KS; Choi CU; Hwang KK; Gwon HC; Jeong MH;
J Am Coll Cardiol; 2021 Apr; 77(15):1859-1870. PubMed ID: 33858622
[TBL] [Abstract][Full Text] [Related]
8. Myocardial salvage after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction presenting early versus late after symptom onset.
Stiermaier T; Eitel I; de Waha S; Pöss J; Fuernau G; Thiele H; Desch S
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1571-1579. PubMed ID: 28439734
[TBL] [Abstract][Full Text] [Related]
9. Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]).
Gierlotka M; Gasior M; Wilczek K; Hawranek M; Szkodzinski J; Paczek P; Lekston A; Kalarus Z; Zembala M; Polonski L
Am J Cardiol; 2011 Feb; 107(4):501-8. PubMed ID: 21195380
[TBL] [Abstract][Full Text] [Related]
10. Delayed angioplasty is superior to an emergency strategy in ST-segment elevation myocardial infarction patients who present late and with infarct artery spontaneous reperfusion before intervention.
Li M; Wu Z; Yuan Y; Feng L; Lao Y; Guo Z
Cardiovasc J Afr; 2019 May/Jun 23; 30(3):162-167. PubMed ID: 31144708
[TBL] [Abstract][Full Text] [Related]
11. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
Cox DA; Stone GW; Grines CL; Stuckey T; Zimetbaum PJ; Tcheng JE; Turco M; Garcia E; Guagliumi G; Iwaoka RS; Mehran R; O'Neill WW; Lansky AJ; Griffin JJ;
Am J Cardiol; 2006 Aug; 98(3):331-7. PubMed ID: 16860018
[TBL] [Abstract][Full Text] [Related]
12. Electrocardiogram to predict reperfusion success in late presenters with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Topal DG; Nepper-Christensen L; Lønborg J; Ahtarovski KA; Tilsted HH; Sørensen R; Pedersen F; Joshi F; Bang LE; Fakhri Y; Helqvist S; Holmvang L; Høfsten D; Køber L; Kelbæk H; Vejlstrup N; Engstrøm T
J Electrocardiol; 2020; 59():74-80. PubMed ID: 32007909
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
[TBL] [Abstract][Full Text] [Related]
14. Therapy for ST-segment elevation myocardial infarction patients who present late or are ineligible for reperfusion therapy.
Cohen M; Boiangiu C; Abidi M
J Am Coll Cardiol; 2010 May; 55(18):1895-906. PubMed ID: 20430260
[TBL] [Abstract][Full Text] [Related]
15. Intracoronary Eptifibatide During Primary Percutaneous Coronary Intervention in Early Versus Late Presenters with ST Segment Elevation Myocardial Infarction: A Randomized Trial.
Elbadawi A; Gasioch G; Elgendy IY; Mahmoud AN; Ha LD; Ashry HA; Shahin H; Hamza MA; Abuzaid AS; Saad M
Cardiol Ther; 2016 Dec; 5(2):203-213. PubMed ID: 27844422
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit from recent changes in management of men and women with ST-segment elevation myocardial infarction treated with percutaneous coronary interventions.
Zandecki Ł; Sadowski M; Janion M; Kurzawski J; Gierlotka M; Poloński L; Gąsior M
Cardiol J; 2019; 26(5):459-468. PubMed ID: 29924379
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial.
Henriques JP; Hoebers LP; Råmunddal T; Laanmets P; Eriksen E; Bax M; Ioanes D; Suttorp MJ; Strauss BH; Barbato E; Nijveldt R; van Rossum AC; Marques KM; Elias J; van Dongen IM; Claessen BE; Tijssen JG; van der Schaaf RJ;
J Am Coll Cardiol; 2016 Oct; 68(15):1622-1632. PubMed ID: 27712774
[TBL] [Abstract][Full Text] [Related]
18. [Management of ST-elevation myocardial infarction in the Umbria region: results from the observational prospective Umbria-STEMI registry].
Angeli F; Del Pinto M; Rasetti G; Patriarchi F; Cocchieri M; Mandorla S; Maragoni G; Giordano G; Giombolini C; Verdecchia P; Romagnoli C; Cavallini C; ;
G Ital Cardiol (Rome); 2010 May; 11(5):393-401. PubMed ID: 20860159
[TBL] [Abstract][Full Text] [Related]
19. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
[TBL] [Abstract][Full Text] [Related]
20. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
